These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 11007727

  • 1. Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study.
    Lyketsos CG, Sheppard JM, Steele CD, Kopunek S, Steinberg M, Baker AS, Brandt J, Rabins PV.
    Am J Psychiatry; 2000 Oct; 157(10):1686-9. PubMed ID: 11007727
    [Abstract] [Full Text] [Related]

  • 2. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
    Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C, Baker AS, Sheppard JM, Frangakis C, Brandt J, Rabins PV.
    Arch Gen Psychiatry; 2003 Jul; 60(7):737-46. PubMed ID: 12860778
    [Abstract] [Full Text] [Related]

  • 3. Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS.
    Mayer LS, Bay RC, Politis A, Steinberg M, Steele C, Baker AS, Rabins PV, Lyketsos CG.
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):930-6. PubMed ID: 16955427
    [Abstract] [Full Text] [Related]

  • 4. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
    Ravindran AV, Guelfi JD, Lane RM, Cassano GB.
    J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
    Lydiard RB, Stahl SM, Hertzman M, Harrison WM.
    J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
    [Abstract] [Full Text] [Related]

  • 6. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
    Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B.
    Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749
    [Abstract] [Full Text] [Related]

  • 7. Sertraline for the treatment of depression in Alzheimer disease.
    Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, DIADS-2 Research Group.
    Am J Geriatr Psychiatry; 2010 Feb; 18(2):136-45. PubMed ID: 20087081
    [Abstract] [Full Text] [Related]

  • 8. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.
    Schneider LS, Nelson JC, Clary CM, Newhouse P, Krishnan KR, Shiovitz T, Weihs K, Sertraline Elderly Depression Study Group.
    Am J Psychiatry; 2003 Jul; 160(7):1277-85. PubMed ID: 12832242
    [Abstract] [Full Text] [Related]

  • 9. Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?
    Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG, DIADS-2 Research Group.
    Int J Geriatr Psychiatry; 2011 Jun; 26(6):573-83. PubMed ID: 20672243
    [Abstract] [Full Text] [Related]

  • 10. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
    Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W.
    Arch Gen Psychiatry; 1996 Sep; 53(9):777-84. PubMed ID: 8792754
    [Abstract] [Full Text] [Related]

  • 11. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
    Mehtonen OP, Søgaard J, Roponen P, Behnke K.
    J Clin Psychiatry; 2000 Feb; 61(2):95-100. PubMed ID: 10732656
    [Abstract] [Full Text] [Related]

  • 12. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
    Hirschfeld RM, Russell JM, Delgado PL, Fawcett J, Friedman RA, Harrison WM, Koran LM, Miller IW, Thase ME, Howland RH, Connolly MA, Miceli RJ.
    J Clin Psychiatry; 1998 Dec; 59(12):669-75. PubMed ID: 9921701
    [Abstract] [Full Text] [Related]

  • 13. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression.
    Murray V, von Arbin M, Bartfai A, Berggren AL, Landtblom AM, Lundmark J, Näsman P, Olsson JE, Samuelsson M, Terént A, Varelius R, Asberg M, Mårtensson B.
    J Clin Psychiatry; 2005 Jun; 66(6):708-16. PubMed ID: 15960563
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.
    Finkel SI, Mintzer JE, Dysken M, Krishnan KR, Burt T, McRae T.
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):9-18. PubMed ID: 14716694
    [Abstract] [Full Text] [Related]

  • 19. Preventing depression after stroke: Results from a randomized placebo-controlled trial.
    Almeida OP, Waterreus A, Hankey GJ.
    J Clin Psychiatry; 2006 Jul; 67(7):1104-9. PubMed ID: 16889454
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.